v3.26.1
Unaudited Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue, net $ 1,071 $ 1,257
Cost of revenue, net 1,041 443
Gross profit 30 814
Operating expenses:    
Research and development 1,131 484
Sales and marketing 3,061 245
General and administrative 8,209 4,014
Total operating expenses 12,401 4,743
Income (loss) from operations (12,371) (3,929)
Non-operating income(expense):    
Investment income 3,401 333
Other income (loss) (1,181) (25,965)
Interest expense, net (2) (4)
Total other income / (expense), net 2,218 (25,636)
Loss before income tax expense (10,153) (29,565)
Income tax benefit/(expense)
Consolidated net loss (10,153) (29,565)
Less: Net loss attributable to non-controlling interest (“NCI”) (8) (21)
Net loss attributable to common stockholders $ (10,145) $ (29,544)
Basic net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
Diluted net loss per share of common stock (in Dollars per share) $ (0.05) $ (0.31)
Weighted average shares used to compute basic net loss per share (in Shares) 197,731,671 95,785,054
Weighted average shares used to compute diluted net loss per share (in Shares) 197,731,671 95,785,054